Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients
about
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTCardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic trainingMetabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.
P2860
Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients
@ast
Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients
@en
Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients
@nl
type
label
Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients
@ast
Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients
@en
Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients
@nl
prefLabel
Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients
@ast
Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients
@en
Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients
@nl
P2093
P2860
P3181
P1476
Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients
@en
P2093
Bernard Lawrence Marini
Craig Alan Byersdorfer
David G. Frame
Simon Cronin
Sung Won Choi
P2860
P304
P3181
P356
10.1016/J.BBMT.2014.10.027
P407
P577
2015-05-01T00:00:00Z